Uterine Hemorrhage: Clinical Trials

98 trials for Uterine Hemorrhage, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

58 completed, 19 unknown, 7 terminated, 7 withdrawn. 98 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 498Completed 58, Unknown 19, Terminated 7, Withdrawn 7, Recruiting 5, Not yet recruiting 2

Follow Uterine Hemorrhage: new trials by email Literature Review of Uterine Hemorrhage trials Research Report on Uterine Hemorrhage

Trials (filtered) newest first · largest first

All 98 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Carbetocin Monotherapy Versus Carbetocin Plus Oxytocin Infusion in Elective Cesarean Delivery: A Non-Inferiority Trial
Carbetocin, Oxytocin, Placebo Saline Infusion - Postpartum Hemorrhage, Uterine Atony
Phase 4RecruitingMansoura University3322026-08-082026-10-09
Oxytocin Bolus Versus Infusion in High-Risk Patients Undergoing Elective Cesarean Section (INBOX-HR)
Oxytocin Bolus or Oxytocin Infusion - Postpartum Hemorrhage, Uterine Atony
Phase 4Not yet recruitingStony Brook University1802026-08-012026-08-03
Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy
Cyclobenzaprine - Minimally Invasive Surgical Procedures, Abnormal Uterine Bleeding, Unspecified
Phase 4Not yet recruitingChristiana Care Health Services362026-07-012026-06-24
Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage
Carbetocin, Oxytocin - Postpartum Hemorrhage, Twin Pregnancy
Phase 4RecruitingSheba Medical Center1202026-05-052026-05-08
A Research Study to See How Safe is Eptacog Alfa When Used to Stop Heavy Bleeding in Women After Giving Birth in India
Eptacog alfa (NovoSeven) - Severe Postpartum Haemorrhage
Phase 4RecruitingNovo Nordisk A/S642025-08-262026-09-25
Comparing Intra-Umbilical Versus Intravenous Oxytocin in Women During the Third Stage of Labor for Reducing Blood Loss
Oxytocin after delivery, Intraumbilical oxytocin - Postpartum Bleeding, Oxytocin
Phase 4CompletedCMH Multan Institute of Medical Sciences602025-08-132026-05-05
Myo-Inositol and D-Chiro-Inositol for Menstrual Irregularities and Hormone Changes in Women With Polycystic Ovarian Syndrome
Myo-Inositol and D-Chiro-Inositol Combination Therapy, placebo (folic acid) - Polycystic Ovary Syndrome (PCOS), Myo-inositol
Phase 4CompletedNishtar Medical University602025-06-012026-07-14
Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage
tranexamic acid, normal saline - Postpartum Hemorrhage, Systemic Autoimmune Diseases
Phase 4RecruitingRenJi Hospital2762025-01-062025-03-17
SWIFT - SWIss Factor XIII Trial in PPH
Fibrogammin - Postpartum Hemorrhage, Coagulation Disorder
Phase 4RecruitingChristian Haslinger9882024-07-092026-04-27
TRanEXamic Acid to Decrease Heavy Menstrual Bleeding in Individuals Anticoagulated for Venous Thromboembolism Pilot Study
Tranexamic acid, No Tranexamic acid - Venous Thromboembolism, Venous Thromboses
Phase 4UnknownUniversity Health Network, Toronto202024-06-012024-06-12
Rate of Tranexamic Acid Administration on Blood Pressure (RateTXA) Study.
Tranexamic Acid (TXA) - Healthy Participants
Phase 4CompletedUniversity of British Columbia1102024-03-302026-10-08
Comparison of the Efficacy of Misoprostol and Tranexamic Acid for Postpartum Hemorrhage Prophylaxis in Cesarean Delivery
Tranexamic acid, Misoprostol 200mcg Tab - Postpartum Hemorrhage, Cesarean Section Complications
Phase 4CompletedAnkara Etlik City Hospital1922023-12-012026-08-06
Pre Versus Post-operative Misoprostol in Reducing Blood Loss After Cesarean Section
Misoprostol 200mcg Tab, Misoprostol Pill - Misoprostol Allergy
Phase 4UnknownCairo University1202023-06-012023-08-23
Comparison Of The Effects Of Carbetocin And Oxytocin In C-Sectıon
C-sections operations, Oxytocin, Carbetocin - Carbetocin, Oxytocic Drugs Causing Adverse Effects in Therapeutic Use
Phase 4UnknownEge University2002023-03-092023-03-07
Prophylactic Methylergonovine for Twin Cesarean
Methylergonovine, Placebo - Twin; Complicating Pregnancy, Postpartum Hemorrhage
Phase 4CompletedColumbia University662023-03-072025-06-13
Use of Chitosan Powder in Loop Electrosurgical Excision Procedure
Chitosan - Vaginal Bleeding, Loop Electrosurgical Excision
Phase 4CompletedErzincan Military Hospital1302022-12-152024-06-26
Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)
Myfembree Oral Product - Metrorrhagia, Pelvic Pain
Phase 4WithdrawnUniversity of Chicago2022-11-202026-06-05
Use of Tranexamic Acid After Vaginal Delivery with Episiotomy a RCT Placebo Control Trail
Tranexamic acid, Placebo - Episiotomy Wound, Anemia
Phase 4CompletedAssuta Ashdod Hospital1502022-07-252024-12-05
Tamoxifen Versus Estradiol for Unscheduled Bleeding in Etonogestrel Implant Users, a Randomized Pilot Trial
Tamoxifen Citrate 10Mg Tab, Estradiol, Placebo - Vaginal Bleeding
Phase 4WithdrawnVirginia Commonwealth University2022-05-012022-06-03
A Trial of Sublingual Misoprostol to Reduce Primary Postpartum Haemorrhage After Vaginal Delivery
Misoprostol - Primary Postpartum Hemorrhage, Misoprostol
Phase 4UnknownThe University of Hong Kong13002022-04-012022-03-03

Showing 20 of 98. Sign in to see all of them.

Narrower conditions

Postpartum Hemorrhage (59)  ·  Menorrhagia (26)  ·  Metrorrhagia (17)  ·  Hemorrhage (10)  ·  Uterine Inertia (10)  ·  Leiomyoma (8)  ·  Hemostatic Disorders (5)  ·  Anemia (4)  ·  Blood Loss, Surgical (4)  ·  Adenomyosis (3)  ·  Agnosia (3)  ·  Pain (3)  ·  Anemia, Iron-Deficiency (2)  ·  Menstruation Disturbances (2)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (98)  ·  Pathologic Processes (98)  ·  Pathological Conditions, Signs and Symptoms (98)  ·  Urogenital Diseases (98)  ·  Hemorrhage (88)  ·  Obstetric Labor Complications (59)  ·  Puerperal Disorders (59)  ·  Pregnancy Complications (58)  ·  Female Urogenital Diseases (39)  ·  Genital Diseases (39)  ·  Genital Diseases, Female (39)  ·  Uterine Diseases (39)  ·  Menstruation Disturbances (24)  ·  Hematologic Diseases (11)

Interventions

Misoprostol (16)  ·  Tranexamic Acid (16)  ·  carbetocin (16)  ·  Oxytocin (15)  ·  Saline Solution (4)  ·  Sodium Chloride (4)  ·  Estradiol (3)  ·  Levonorgestrel (3)  ·  Tamoxifen (3)  ·  ulipristal acetate (3)  ·  Ethinyl Estradiol-Norgestrel Combination (2)  ·  Folic Acid (2)  ·  Iron (2)  ·  Ketorolac (2)  ·  Ketorolac Tromethamine (2)

Sponsors

Cairo University (5)  ·  Gynuity Health Projects (4)  ·  Assiut University (3)  ·  Beni-Suef University (3)  ·  Oregon Health and Science University (3)  ·  Bayer (2)  ·  Erzincan Military Hospital (2)  ·  Scott and White Hospital & Clinic (2)  ·  Talkha Central Hospital (2)  ·  AbbVie (1)  ·  Abimbola Famuyide (1)  ·  Ain Shams Maternity Hospital (1)  ·  Al-Kindy College of Medicine (1)  ·  Ankara Etlik City Hospital (1)  ·  Aristotle University Of Thessaloniki (1)

Countries

United States (33)  ·  Egypt (17)  ·  Canada (4)  ·  France (4)  ·  Turkey (Türkiye) (4)  ·  Israel (3)  ·  Switzerland (3)  ·  Brazil (2)  ·  China (2)  ·  Finland (2)  ·  Greece (2)  ·  Ireland (2)  ·  Pakistan (2)  ·  Vietnam (2)  ·  Argentina (1)

Top investigators

Beverly Winikoff, MD, MPH (2)  ·  Nesreen A Shehata, MD (2)  ·  Patricia J Sulak, MD (2)  ·  Abimbola O. Famuyide, MBBS (1)  ·  Ahmed Maged (1)  ·  Ahmed Maged, MD (1)  ·  Ahmed S Alnuaimi, PhD (1)  ·  Alaa A Hussein, FICOG, MD (1)  ·  Alan T Tita, MD, PhD (1)  ·  Amanda Yunker, DO (1)

Results publications

PMID 12738159, PMID 16108235, PMID 16309682, PMID 16934269, PMID 17012482, PMID 17027730, PMID 19955104, PMID 20378611, PMID 20472114, PMID 20554319, PMID 21162725, PMID 22227638, PMID 23635728, PMID 23728648, PMID 24405687, PMID 24682613, PMID 24788209, PMID 25571934, PMID 25594352, PMID 25600160, PMID 26079202, PMID 26118386, PMID 26226243, PMID 26534874, PMID 26698831, PMID 26952346, PMID 27419258, PMID 27558956, PMID 27607864, PMID 28456509, PMID 29141040, PMID 31226322, PMID 31304593, PMID 31736069, PMID 31777949, PMID 32143721, PMID 32176833, PMID 32448257, PMID 32649493, PMID 33169839, PMID 33232518, PMID 33713384, PMID 34932836, PMID 37116825, PMID 37769311, PMID 38954680, PMID 39326051, PMID 39934771, PMID 40345697, PMID 41114449

NIH funding

2005 (1), 2009 (1), K12HD001258 (1), R21HD091337 (1)